Obesity is known to be influenced by a number of genes, including the β3 subunit of
G protein (GNB3), β3-adrenergic receptor (ADRB3),
uncoupling protein 2 (UCP2), and
peroxisome proliferator activated receptor gamma (PPARγ). The single nucleotide polymorphisms (SNPs) of the above genes, such as GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala, are associated with
obesity and body mass index. The present study evaluates the impact of
Bofutsushosan, a traditional Eastern Asian herbal medicine with known anti-
obesity properties, on obese subjects according to the presence of the above-mentioned SNPs. Upon randomization, the volunteers were allocated to receive
Bofutsushosan (n=55) or placebo (n=56) treatments for 8 weeks. Following the treatment schedule, significant reductions in total
cholesterol and significant improvement in the Korean version of
obesity-related quality of life scale were seen in the
Bofutsushosan-treated group, but not in placebo.
Bofutsushosan exerted significant anti-
obesity effects on a number of parameters in the carriers of the GNB3-825T allele, but only on waist circumference in the GNB3-C/C homozygote. Significant anti-
obesity impact of
Bofutsushosan was also seen on a number of
obesity-indices in both ADRB3-Arg64 carriers and ADRB3-Trp64 homozygotes, as well as in UCP2-
D/D carriers, but not in UCP2-D/I+I/I variants. The effect of
Bofutsushosan was more pronounced in PPARγ-
Pro/Pro genotype compared to PPARγ-Pro/Ala variants. Thus, the results revealed differential responses of the subjects to the anti-
obesity effects of
Bofutsushosan treatment according to the polymorphism of the vital
obesity-related genes. Our study provides new insight into individualized clinical applications of
Bofutsushosan for
obesity.